Dr Pedro M Kareh-cordero, MD | |
201 Ave Gautier Benitez, Consolidated Medical Plaza, Suite 306, Caquas, PR 00725 | |
(787) 745-8515 | |
(787) 746-9044 |
Full Name | Dr Pedro M Kareh-cordero |
---|---|
Gender | Male |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 38 Years |
Location | 201 Ave Gautier Benitez, Caquas, Puerto Rico |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1992781520 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | H7348 (Puerto Rico) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Pedro M Kareh-cordero, MD Po Box 6317, Caguas, PR 00726-6317 Ph: (787) 745-8515 | Dr Pedro M Kareh-cordero, MD 201 Ave Gautier Benitez, Consolidated Medical Plaza, Suite 306, Caquas, PR 00725 Ph: (787) 745-8515 |
News Archive
A multidisciplinary team from the Montreal Heart Institute (MHI) performed its first catheter implantation of a new prosthesis (Amptlazer(R) Cardiac Plug) closing the appendage of the left atrium of the heart, which will have the effect of preventing the formation of blood clots and avoiding open-heart surgery. This is excellent news for patients suffering from atrial fibrillation, the most common form of cardiac arrhythmia, affecting at least 5% of Canadians over the age of 70.
What if you had to plan your outings based on how your stomach felt that day or where the nearest restroom is located? For many people with inflammatory bowel disease (IBD), their guts have an inordinate effect on their daily quality of life.
A new publication illustrates the burden that chronic illnesses impose on American society, demonstrating through charts and graphics how 60 percent of American adults suffer from at least one chronic health condition and 42 percent have more than one.
Janssen-Cilag International NV has announced the submission of a Type II variation application to the European Medicines Agency (EMA), seeking to broaden the existing marketing authorisation for the immunotherapy DARZALEX® (daratumumab) to include treatment of adult patients with relapsed multiple myeloma who have received at least one prior therapy. The expanded indication is based on daratumumab in combination with lenalidomide (an immmunomodulatory agent) and dexamethasone, or bortezomib (a PI) and dexamethasone.
They are common suggestions to remedy stress: You just need a breath of fresh air. Walk it off. Get out and see people.
› Verified 4 days ago
Dr. Ivya E Diaz Vidal, MD INTERNAL MEDICINE Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: Ave Luis Munoz Marin 50, Quadrangle Medical Suite 106, Caquas, PR 00726 Phone: 787-745-0022 Fax: 787-739-7199 |